Bank Mutual Corporation operates as the holding company for Bank Mutual that provides various financial products and services in Wisconsin. The company offers regular savings accounts, interest-bearing and noninterest-bearing demand accounts, money market accounts, and certificates of deposit, as well as IRA time deposit accounts and health savings accounts for retail and business customers. It also provides multi-family and commercial real estate loans that are secured by apartment buildings, office buildings, retail centers, warehouses, and industrial buildings; construction and development loans; residential mortgage loans; and commercial and industrial loans, such as loans to businesses for equipment purchases, working capital, debt refinancing or restructuring, business acquisition or expansion, small business administration, and domestic standby letters of credit. In addition, the company offers home equity loans and home equity lines of credit; and consumer loans consisting of student loans, automobile loans, recreational vehicle and boat loans, deposit account loans, and overdraft protection lines of credit, as well as unsecured consumer loans, including loans through credit card programs. Further, it provides investment services, including tax-deferred and tax-free investments, mutual funds, and government securities; and brokerage and insurance services related to personal insurance, business insurance, property and casualty insurance, credit life and disability insurance, and mortgage protection products, as well as offers investment advisory services. As of May 05, 2014, the company operated 75 banking offices in Wisconsin and 1 in Minnesota. Bank Mutual Corporation was founded in 1892 and is headquartered in Milwaukee, Wisconsin.
Kingsway Financial Services Inc., through its subsidiaries, is engaged in the provision of property and casualty insurance products for individuals and businesses in the United States. The company operates in two segments, Insurance Underwriting and Insurance Services. The Insurance Underwriting segment offers various automobile insurance products, including liability insurance that covers claims against its insured's responsible for automobile accidents; accident benefit policies or personal injury protection policies that provide coverage for loss of income, medical, and rehabilitation expenses for insured persons who are injured in an automobile accident; and physical damage policies, which cover damages to an insured automobile arising from a collision with another object or from other risks, such as fire or theft. This segment also provides homeowners policies for wind and hail-related property losses of residential dwellings and various contents. The Insurance Services segment operates as a licensed property and casualty agent, full service managing general agent, and third-party administrator focused primarily on the assigned risk market; and markets and administers vehicle service agreements and related products for new and used automobiles. The company markets its products and services through a network of independent agencies. Kingsway Financial Services Inc. was founded in 1989 and is based in Toronto, Canada.
Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders in the United States. Its product portfolio includes Androxal, an oral therapy, which is in Phase III clinical trials for the treatment of low testosterone due to secondary hypogonadism; and Proellex that is in Phase II clinical trials for the treatment of symptoms associated with uterine fibroids and endometriosis. The company has a license agreement with the National Institutes of Health to develop and commercialize Proellex. Repros Therapeutics Inc. was founded in 1987 and is based in The Woodlands, Texas.
First Mid-Illinois Bancshares, Inc. operates as the holding company for First Mid-Illinois Bank & Trust, N.A. that provides community banking and wealth management services to commercial, retail, and agricultural customers in Illinois. The company's deposit products include demand, savings, money market, and time deposits, as well as NOW accounts. Its loan portfolio primarily comprise commercial real estate, commercial and industrial, agricultural and agricultural real estate, residential real estate, and consumer loans; and other loans consisting of loans to municipalities to support community projects, such as infrastructure improvements or equipment purchases. The company also offers estate planning, investment, and farm management services to individuals; and employee benefit services for business enterprises. In addition, it provides commercial lines insurance to businesses; and homeowner, automobile, and other types of personal lines insurance to individuals. The company serves communities of central Illinois with 37 branches in Galesburg, Knoxville, Bartonville, Peoria, Bloomington, Mansfield, Mahomet, Weldon, Urbana, Monticello, Champaign, Decatur, Tuscola, Quincy, Tuscola, Arcola, Taylorville, Sullivan, Charleston, Mattoon, Neoga, Altamont, Effingham, Maryville, Pocahontas, and Highland. First Mid-Illinois Bancshares, Inc. was founded in 1865 and is headquartered in Mattoon, Illinois.
Prospect Capital Corporation is a business development company. It specializes in middle market, mature, mezzanine finance, later stage, emerging growth, buyouts, recapitalizations, turnaround, growth capital, development, subordinated debt tranches of collateralized loan obligations, cash flow term loans, and bridge transactions. It also makes real estate investments particularly in multi-family residential real estate asset class. The fund makes secured debt, senior debt, unitranche debt, first-lien and second lien, private debt, mezzanine debt, and equity investments in private and microcap public businesses. It typically invests across all industry sectors, with a particular expertise in the energy and industrial sectors. The fund invests in aerospace and defense, chemicals, conglomerate services, consumer services, ecological, electronics, financial services, machinery, manufacturing, media, pharmaceuticals, retail, software, specialty minerals, textiles and leather, transportation, oil and gas production, coal production, materials, industrials, consumer discretionary, information technology, utilities, pipeline, storage, power generation and distribution, renewable and clean energy, oilfield services, healthcare, food and beverage, education, business services, and other select sectors. It prefers to invest in the United States and Canada. The fund seeks to invest between $10 million to $250 million per transaction in companies with EBITDA between $5 million and $150 million, sales value between $25 million and $500 million, and enterprise value between $5 million and $1000 million. It fund also co-invests for larger deals. The fund seeks control acquisitions by providing multiple levels of the capital structure. The fund focuses on sole, agented, club, or syndicated deals.
Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) based on its proprietary T-cell technology. Its product candidate is Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS. The company was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in June 2006. Opexa Therapeutics was founded in 2003 and is based in The Woodlands, Texas.
Opko Health, Inc., a biopharmaceutical and diagnostics company, is engaged in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. The company develops a range of solutions to diagnose, treat, and prevent various conditions, including point-of-care tests, laboratory developed tests, molecular diagnostics tests, and proprietary pharmaceuticals, and vaccines. Its product pipeline includes various pharmaceutical compounds and technologies in research and development for a range of indications and conditions. The company's lead products comprise RayaldyTM, a vitamin D prohormone, which in phase III clinical development stage to treat secondary hyperparathyroidism in patients with stage III or IV chronic kidney disease and vitamin D insufficiency; and Alpharen, a new and potent non-absorbed phosphate binder to treat hyperphosphatemia in dialysis patients. It also manufactures, sells, and licenses specialty active pharmaceutical ingredients for pharmaceutical companies. In addition, the company is involved in the discovery of new drugs for the treatment of various illnesses, including cancer, heart disease, metabolic disorders, and genetic anomalies; and developing a protein-based influenza vaccine that would offer protection against influenza, as well as has various therapeutic agents for respiratory disorders in clinical development, including products for asthma, chronic obstructive pulmonary disease, and chronic cough. Further, it develops rolapitant, a potent and selective competitive antagonist that has completed phase II clinical testing for prevention of chemotherapy induced nausea and vomiting. It also operates OPKO Lab, a full-service medical laboratory specializing in urologic pathology. The company operates in the United States, Chile, Spain, Israel, Mexico, and Ireland. OPKO Health, Inc. is based in Miami, Florida.
American Homes 4 Rent is a real estate investment trust. The firm engages in the acquisition, renovation, leasing, and operating single-family home rental properties in the United States. American Homes 4 Rent was founded in 2012 and is based in Malibu, California.
NV5 Holdings, Inc. provides professional and technical engineering, and consulting solutions to public and private sectors. The company offers infrastructure, engineering, and support services, such as site selection, design, construction and program management, water resources, transportation, structural engineering, land development, surveying, and other services. It also provides construction quality assurance services, including construction materials testing and engineering, geotechnical engineering and consulting, and forensic consulting; and program management services consisting of governmental outsourcing and consulting services, as well as technical outsourcing services, including traffic studies, building code plan review, code enforcement, permitting and inspections, and the administration of public works projects, building departments, and safety departments. In addition, the company offers energy services comprising inspection, program management, and assistance in permitting; and traditional engineering services, including energy transmission and distribution, underground transmission and distribution, substation engineering, power generation facility design services, and surveying. Further, it provides environmental services, such as investigating and analyzing environmental conditions both outside and inside a building, and recommending corrective measures and procedures; occupational health and safety services, including workplace safety audits, ergonomics studies, plans for emergency preparedness, and workplace monitoring; hydrogeological modeling and environmental programs for groundwater resource assessments; water resource planning, monitoring, and environmental management of wastewater facilities; solid waste landfill investigations; storm water pollution; environmental impact statement support; agricultural waste management and permitting; and wetland evaluations. The company was founded in 1949 and is based in Hollywood, Florida.
Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, manufacturing, and marketing of products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar, and intervertebral regions of the spine, as well as covers various spinal disorders and surgical procedures. The company offers cervical and cervico-thoracic products, including Trestle Anterior Cervical Plate; Trestle Luxe Anterior Cervical Plate; Solanas Posterior Cervico/Thoracic Fixation system; and Avalon Occipital Plate. It also provides thoracolumbar fixation products, such as Zodiac Degenerative Fixation System, Zodiac Deformity Fixation System with Smart Set, ILLICO FS Fixation System, Xenon Fixation System, BridgePoint Spinous Process Fixation System, Aspida Anterior Lumbar Interbody Plate System, Hemi Fixation System, and OsseoFix+ Vertebroplasty System. In addition, it company offers Spinal Spacers comprising Novel Spinal Spacers, Alphatec Solus Locking ALIF Spacer, and Pegasus Anchored Cervical Interbody; Minimally Invasive Surgery (MIS) products, including Illico MIS System and BridgePoint Spinous Process Fixation System; and Biologics, such as AlphaGraft Structural Allograft Spacers, AlphaGraft Demineralized Bone Matrix, AlphaGraft ProFuse Demineralized Bone Scaffolds, AmnioShield Amniotic Membrane, and NEXoss Synthetic Bone Graft. Alphatec Holdings sells its products through independent distributors in approximately 50 countries worldwide. The company also provides DiscoCerv Artificial Disc, PCB Evolution, TTL IN Fixation System, Isobar Evolution Dynamic Rod, TTL-D Fixation System, OsseoFix Spinal Fracture Reduction System, OsseoScrew Spinal Fixation System, Samarys/Samarys RF, HeliFix Interspinous Spacer System, TeCorp, OsseoScrew MIS System, and Epicage TLIF System outside of the United States. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.